Back
InterCure Ltd. 10K Form
Sell
31
INCR
InterCure Ltd.
Last Price:
$1.29
Seasonality Move:
4.38%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive INCR News And Ratings
See the #1 stock for the next 7 days that we like better than INCR
INCR Financial Statistics
Sales & Book Value
| Annual Sales: | $64.5M |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $2.68 |
| Price / Book: | 0.52 |
Profitability
| EPS (TTM): | -0.11210 |
|---|---|
| Net Income (TTM): | $-1.8M |
| Gross Margin: | $3.8M |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
InterCure Ltd. Earnings Forecast
Key InterCure Ltd. Financial Ratios
-
The Gross Profit Margin over the past 18 years for INCR is 5.88%.
-
The Selling, General & Administrative Expenses for INCR have been equal to 45.17% of Gross Profit Margin.
-
The Research & Development expenses have been 0.17% of Revenue.
-
The Net Earning history of INCR is -30.48% of Total Revenues.
-
Per Share Earnings over the last 18 years have been positive in 11 years.
InterCure Ltd. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | INCR |
| Website: | intercure.co |
Debt
| Debt-to-Equity Ratio: | 0.29 |
|---|---|
| Current Ratio: | 1.78 |
| Quick Ratio: | 1.15 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
INCR Technical Analysis vs Fundamental Analysis
Sell
31
InterCure Ltd. (INCR)
is a Sell
Is InterCure Ltd. a Buy or a Sell?
-
InterCure Ltd. stock is rated a SellThe current InterCure Ltd. [INCR] share price is $1.30. The Score for INCR is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.